Mylan mycophenolate mofetil injection recalled for precipitate
Mylan Pharmaceuticals is recalling one lot of mycophenolate mofetil for injection vials because of the presence of precipitate, which is solid material that has separated out of the liquid. The recall covers 5,688 single-dose vials distributed nationwide. No injuries have been reported.
From the FDA notice · Read the official notice ↗ · All Mylan recalls
What to do
- Talk to your pharmacist or prescriber before stopping this medicine.
- Check whether the vial is lot 3241653 with expiration date 4/30/2027, or whether the carton is NDC 67457-386-81 (vial NDC 67457-386-00).
- The notice doesn't say how to get a refund or replacement; contact Mylan Pharmaceuticals or where you bought it.
Is yours affected?
Compare your label or packaging with the recalled product.
- Product
- Mycophenolate Mofetil for Injection USP, 500 mg/Vial, Single Dose Vial, 4 vials per carton, Rx only, Manufactured for: Mylan Institutional LLC, Morgantown, WV, 26505 USA, Made in India, NDC 67457-386-00 (vial label) & NDC 67457-386-81 (carton label).
- Sold in
- Nationwide
- Made for
- All ages (0 months and older)
Details
- Units affected
- 5688 vials
- Illnesses reported
- None reported
- Manufactured in
- 1311 Pineview Dr, N/A, Morgantown, WV, United States
- Classification
- Class II
- Recall number
- D-0734-2026
In the FDA's words
- Description
- Mycophenolate Mofetil for Injection USP, 500 mg/Vial, Single Dose Vial, 4 vials per carton, Rx only, Manufactured for: Mylan Institutional LLC, Morgantown, WV, 26505 USA, Made in India, NDC 67457-386-00 (vial label) & NDC 67457-386-81 (carton label). Presence of precipitate Lot #: 3241653, Exp 4/30/2027 Distribution: USA Nationwide Affected quantity: 5688 vials
- Hazard
- Presence of precipitate
More from Mylan
See all- Mylan prasugrel 10 mg tablets recalled for failed dissolution testing
ModerateFDASep 9, 2026
- Mylan Mycophenolate Mofetil injection recalled for failed dissolution specifications
ModerateFDASep 9, 2026
- Mylan acamprosate calcium tablets recalled for failed dissolution
ModerateFDAAug 26, 2026